Start the conversation
Nearly 800,000 government employees are still furloughed and about 1 million asked to work without pay as the shutdown enters a third week with no resolution on the federal budget nor an agreement on the debt ceiling.
With stocks sinking, gold is rebounding to 1.1% to $1,282.60 an ounce after closing Friday at its lowest price in three months. Treasuries are also up, and the dollar is down versus the euro.
Crude oil for November delivery is down $0.58 per barrel to $101.44 today.
Stock Market News Today: Healthcare
Several healthcare stocks are making noteworthy gains this morning.
Protalix BioTherapeutics Inc. (NYSEMKT: PLX) was up about 3% in morning trade after announcing initial positive results in its phase 1 clinical trial of its Oral GCD drug in patients with Gaucher's disease.
Protalix said oral GCD was well-tolerated and the active enzyme was detected in patients' blood circulation.
And Antares Pharma Inc. (Nasdaq: ATRS) is up more than 8% at $4.91 in morning trade after the biopharmaceutical company said the U.S. Food and Drug Administration approved its OTREXUP injection, which treats severe active rheumatoid arthritis.
Among the significant downside movers in the stock market news today, Coronado Biosciences Inc. (Nasdaq: CNDO) has plunged about 67% to $1.89 after it said its phase 2 clinical trial evaluating its TSO drug in 250 patients with moderate-to-severe Crohn's disease didn't meet its primary endpoint of improving response. It also didn't meet the key secondary endpoint of remission.
CNDO's lows today are less than half the stock's previous 52-week low of $4.00.